PROFUSA, INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- PROFUSA, INC. payments for repurchase of common stock for the quarter ending 2025-06-30 was $0.00.
- PROFUSA, INC. payments for repurchase of common stock for the quarter ending 2025-03-31 was $6.51M, a 145.37% increase year-over-year.
- PROFUSA, INC. payments for repurchase of common stock for the quarter ending 2024-12-31 was $595.44K.
- PROFUSA, INC. payments for repurchase of common stock for the quarter ending 2024-09-30 was $0.00.
- PROFUSA, INC. payments for repurchase of common stock for fiscal 2024 was $3.25M, a 98.24% decline from fiscal 2023.
- PROFUSA, INC. payments for repurchase of common stock for fiscal 2023 was $184.85M.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $7.11M derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | $6.51M 10-Q · filed 2025-06-13 | $7.11M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-12-31 | $595.44K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $3.25M 10-K · filed 2025-03-31 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-17 | $2.65M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $2.65M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $2.65M 10-Q · filed 2025-06-13 | $2.65M derived: sum of 4 quarters · filed 2025-06-13 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $184.85M 10-K · filed 2025-03-31 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-17 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-15 | |
| 2023-03-31 | $184.85M 10-Q · filed 2024-10-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |